SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-309742
Filing Date
2019-12-10
Accepted
2019-12-10 07:07:02
Documents
3
Period of Report
2019-12-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d839153d8k.htm 8-K 18007
2 EX-99.1 d839153dex991.htm EX-99.1 44686
3 GRAPHIC g839153g1210023854318.jpg GRAPHIC 2761
  Complete submission text file 0001193125-19-309742.txt   67760
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 191276511
SIC: 2834 Pharmaceutical Preparations